₹ 210.80
13.77 (6.99%)
S
Sun Pharma Advanced Research Co
₹ 210.80
SPARC Financials Summary (Consolidated)
Sun Pharma Advanced Research Co revenue decreased 15.57% quarter-on-quarter to ₹54 Cr in Sep 2026, while net loss widened to ₹24 Cr from ₹21 Cr in the previous quarter. Compared to the same quarter last year, revenue is up 579.75% and net loss narrowed to ₹24 Cr from ₹76 Cr a year ago. EPS for the quarter stood at -₹0.75, decreased from -₹0.64 in the previous quarter and up from -₹2.34 a year ago.
Sun Pharma Advanced Research Co Financials
Income Statement
In Cr
Balance Sheet
In Cr
Cash Flow
In Cr
Get In-depth View of SPARC Quaterly Results, Balance Sheet, Cashflows & Corporate Action.
SPARC Revenue Growth
All values are in Crores
Revenue
Profit
Loss

Pay Zero Brokerage on Delivery
Open FREE Demat Account
+91
Or Scan the QR Code to download the Dhan App






